hGSTA3-3 (human Alpha-class glutathione transferase 3-3) efficiently catalyses steroid 5 -4 double-bond isomerization in vitro, using glutathione as a cofactor. This chemical transformation is an obligatory reaction in the biosynthesis of steroid hormones and follows the oxidation of 3β-hydroxysteroids catalysed by 3β-HSD (3β-hydroxysteroid dehydrogenase). The isomerization has commonly been ascribed to a supplementary function of 3β-HSD. The present study is the first to provide evidence that hGSTA3-3 contributes to this step in steroid hormone biosynthesis in complex cellular systems. First, we find glutathione-dependent 5 -4 isomerase activity in whole-cell extracts prepared from human steroidogenic cells. Secondly, effective inhibitors of hGSTA3-3 dramatically decrease the conversion of 5 -androstene-3,17-dione into 4 -androstene-3,17-dione in cell lysates. Thirdly, we show that RNAi (RNA interference) targeting hGSTA3-3 expression decreases by 30 % the forskolin-stimulated production of the steroid hormone progesterone in a human placental cell line. This effect is achieved at low concentrations of two small interfering RNAs directed against distinct regions of hGSTA3-3 mRNA, and is weaker in unstimulated cells, in which hGSTA3-3 expression is low. The results concordantly show that hGSTA3-3 makes a significant contribution to the double-bond isomerization necessary for steroid hormone biosynthesis and thereby complements the indispensable 3β-hydroxysteroid oxidoreductase activity of 3β-HSD. The results indicate that the lower isomerase activity of 3β-HSD is insufficient for maximal rate of cellular sex hormone production and identify hGSTA3-3 as a possible target for pharmaceutical intervention in steroid hormone-dependent diseases.
INTRODUCTION
The biosynthesis of steroid hormones in humans is a multistep process involving several enzymes present in the endoplasmic reticulum and in the cytosol [1] . The first step in the production of all steroid hormones is the transfer of cholesterol from the outer to the inner mitochondrial membrane in a process mediated by the StAR (steroidogenic acute regulatory protein). Subsequently, cytochromes P450 and steroid dehydrogenases catalyse diverse oxidation and isomerization reactions leading to the production of the active hormones. The 5 -4 double-bond isomerization in the steroid nucleus is an obligatory chemical transformation along the biosynthetic pathway of all steroid hormones. This reaction is generally ascribed to the enzyme 3β-HSD (3β-hydroxysteroid dehydrogenase), which exhibits two different enzymatic activities [1] . First, 3β-HSD catalyses the dehydrogenation of 5 -hydroxysteroids to 5 -ketosteroids. Secondly, the 5 -ketosteroids are isomerized to 4 -ketosteroids. 3β-HSD is not the sole enzyme capable of isomerizing steroids. It has been known for a long time that some GSTs (glutathione transferases) can catalyse the glutathione-dependent doublebond isomerization of ketosteroids [2] . GSTs are a superfamily of enzymes prominently involved in detoxication reactions, via conjugation of the tripeptide glutathione with potentially harmful electrophilic substances [3] . However, recent studies have uncovered roles for GSTs in other biological processes, such as regulation of signalling protein kinases [4] [5] [6] and biosynthesis of prostaglandins [7] . In vitro studies using recombinant hGSTAs (human Alpha-class GSTs) have revealed that hGSTA3-3 catalyses the 5 -4 isomerization of 5 -AD ( 5 -androstene-3, 17-dione; a precursor of testosterone) and of 5 -PD ( 5 -pregnene-3,20-dione; a precursor of progesterone) 230 and 25 times more efficiently respectively than 3β-HSD [8] . The high steroid isomerase activity of hGSTA3-3 is unparalleled by any other known human enzyme. Among members of the Alpha class, hGSTA1-1 displays only 10 % of the hGSTA3-3 isomerase activity towards 5 -AD, whereas hGSTA2-2 and hGSTA4-4 are significantly less active than hGSTA1-1.
Immunohistochemical studies have shown that GSTAs are selectively localized in the steroidogenic cells of the human ovary [9] . Remarkably, RT-PCR (reverse transcription-PCR) studies have revealed that, among the GSTAs, only hGSTA3-3 exhibits selective expression in steroidogenic tissues [8, 10] . The characteristic tissue distribution and in vitro enzymatic properties of hGSTA3-3 strongly suggest a role for this enzyme in the biosynthesis of steroid hormones in humans. However, direct evidence for such a role in intact human cells is lacking.
Here, we address the question of the involvement of hGSTA3-3 in steroidogenesis in vivo, by studying the production of steroid hormones in cells in which hGSTA3-3 activity or expression is suppressed. We identify potent inhibitors of the steroid isomerase activity of recombinant hGSTA3-3 and design siRNAs (small interfering RNAs) targeting specifically hGSTA3-3 mRNA. We demonstrate that these agents inhibit the ability of human steroidogenic cells expressing hGSTA3-3 to perform isomerization of 5 -AD and to produce progesterone. The present
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study is the first to present evidence for the contribution of hGSTA3-3 in the actual production of sex hormones in living human cells.
EXPERIMENTAL

Chemicals
GSH, CDNB (1-chloro-2,4-dinitrobenzene), EA (ethacrynic acid) and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] were obtained from Sigma-Aldrich. 5 -AD was from Steraloids (Newport, RI, U.S.A.) and TBTA (tributyltin acetate) and tributyltin bromide were from ABCR (Karlsruhe, Germany).
Recombinant enzymes
hGSTA3-3 was heterologously expressed in Escherichia coli BL-21 and purified as described by Johansson and Mannervik [11] . hGSTs A1-1, M1-1, M2-2, M5-5, P1-1 and T1-1 were available in our laboratory. 
Enzymatic activities
Conjugation of GSH to CDNB by the recombinant enzymes was monitored under standard conditions [12] . Isomerization of 5 -AD to 4 -AD was performed as previously described [8] in the presence of 1 mM GSH and 0.1 mM 5 -AD, at 30
• C. The reaction was monitored spectrophotometrically at 248 nm. The molar absorption coefficient ( ) for the 4 -AD product is 16 300 M −1 · cm −1 . Inhibition by EA was examined at concentrations ranging between 0.5 and 50 μM. Concentrations of TBTA varying between 0.025 and 2 μM were used. The measurements were conducted in duplicate and repeated on two different occasions.
For analysis of isomerase activity in cell lysates (see below for preparation of lysates), 15 μl of lysate (from 0.8 × 10 6 to 1.4 × 10 6 cells) was used for each measurement (performed in a final volume of 1 ml). This volume was chosen to allow the highest measurable activity with an acceptable background absorbance at 248 nm. The isomerization of 5 -AD varied linearly between 20 and 100 μM, and a concentration of 60 μM of 5 -AD was chosen for inhibition experiments. The concentration of TBTA was varied between 0.025 and 2 μM and the concentration of EA was varied between 0.5 and 50 μM. DMSO was used as the solvent for CDNB, EA and TBTA, and was present at a final concentration of 2.5 % in the assay system.
Cell culture and treatments
H295R cells were cultured in DMEM (Dulbecco's modified Eagle's medium)/F-12 Ham's medium (Sigma), supplemented with 5 % Nu-Serum (BD Biosciences) and the antibiotics penicillin and streptomycin (Sigma). JEG-3 cells were cultured in MEM (minimal essential medium) supplemented with 10 % (v/v) fetal bovine serum, antibiotics, fungizone and non-essential amino acids (all from Invitrogen). After 24 or 48 h, the culture medium was saved for progesterone analysis and a cytotoxicity test was performed as described below.
Preparation of cell extracts
H295R cell lysates were prepared by lysing cells at 70 % confluency in ice-cold lysis buffer containing 20 mM Hepes/KOH (pH 7.9), 25 % (v/v) glycerol, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 0.4 % Nonidet P40, 0.5 mM PMSF and 0.5 mM DTT (dithiothreitol) [13] [500 μl of buffer/(25-40) × 10
6 cells]. The cell extract was centrifuged at 13 000 g for 15 min and the supernatant was immediately used for activity measurements.
The cytotoxicity test
The MTT test was performed as described by Carmichael et al. [14] with minor modifications. Briefly, the cells were exposed to 0.5 mg of MTT per ml of culture medium and incubated at 37
• C for 1.5 h. The formazan crystals formed were dissolved in DMSO and A 540 was measured.
Progesterone determinations
Progesterone concentrations in the cell medium were measured with an automated immunoassay system (Modular E170, Roche Diagnostics) at the Department of Medical Sciences, Clinical Chemistry, at Uppsala University Hospital. The analytical range extended from 0.1 to 190 nM. The total coefficient of variation was less than 5.5% at all concentration levels. The amount of progesterone produced by the cells was then corrected for the number of viable cells as determined by the MTT assay (see above).
siRNAs
Two siRNAs (small interfering RNAs) (si1 and si2) targeting the coding region of GSTA3 mRNA (GenBank ® accession no. NM_000847, nt 206-226 and nt 464-484 respectively) were used. Si1 sequence: antisense strand, 5 -ACUCCCAUCAUUU-CUUAACTT-3 ; sense strand, 5 -GUUAAGAAAUGAUGGG-AGUTT-3 . Si2 sequence: antisense strand, 5 -GGCAGGGA-AAUAGCGACUUTT-3 ; sense strand, 5 -AAGUCGCUAUU-UCCCUGCCTT-3 . Annealed si1 and si2, and a non-specific siRNA (Silencer TM Negative Control no. 1) were from Ambion.
Transfections
siRNAs were administered to JEG-3 cells by two successive reverse transfections performed with a 48 h interval between them. In the first transfection, the siRNAs complexed with Lipofectamine TM 2000 (Invitrogen) according to the manufacturer's instructions were dispensed into six-well plates. Exponentially growing JEG-3 cells were trypsinized, treated with 10 μM forskolin, and added to the complexes at a density of 2 × 10 5 cells per well. After 48 h, the cells were harvested and submitted to a second reverse transfection. Cell media were analysed for progesterone content and cell toxicity was assayed 48 h after the second transfection.
Semi-quantitative RT-PCR
Total RNA was isolated from JEG-3 cells using a RNeasy Mini kit (Qiagen). Reverse transcription was performed with 2 μg of RNA, using Enhanced Avian Reverse Transcriptase (Sigma) and OligodT (23) (Sigma) . Amplification was performed with Taq polymerase (Fermentas). hGSTA3-specific PCR primers and PCR conditions were as described by Morel et al. [10] . 3β-HSD-specific primers were as designed by Blouin et al. [15] . Optimization was carried out to ensure linearity of the amount of hGSTA3, 3β-HSD and actin PCR products formed. A 0.75 μl portion of the reverse transcription product was chosen as the template for the PCR reactions, and β-actin control primers [16] were added after 17 cycles of amplification. 
Statistics
Results shown are means + − S.D. The statistical analyses were performed with a one-tailed unpaired Student's t test.
RESULTS
Inhibition of the steroid 5 -4 isomerization catalysed by hGSTA3-3
Organometallic compounds and the diuretic substance EA are potent inhibitors of GST-catalysed reactions [17] [18] [19] . In order to gain a deeper insight into the selectivity of the inhibitory effect of these compounds for hGSTA3-3, we tested the ability of EA and of two organometals to inhibit reactions catalysed by purified recombinant hGSTA3-3 and by several other GSTs. The conjugation of GSH to CDNB by recombinant hGSTs A1-1, A2-2, A3-3, M2-2 and P1-1 was monitored in the presence of the inhibitors and the IC 50 was determined. In parallel, the effect of the substances on the steroid isomerization reaction catalysed by hGSTA3-3 and hGSTA1-1 was evaluated. The results are presented in Table 1 . The observed IC 50 values indicate that organotin compounds tend to be stronger inhibitors of GSTAs than most GSTs from other classes. The strongest inhibitory effect was in the low nanomolar range and was observed for TBTA on the conjugation of CDNB by hGSTA3-3. TBTA was a potent inhibitor of the hGSTA3-3-and hGSTA1-1-catalysed steroid isomerization as well. EA also inhibited this reaction efficiently, although with an IC 50 in the micromolar range. EA and TBTA were chosen for further inhibition studies using a more complex biological system, represented by crude lysates prepared from human steroidogenic cells.
GSTA expression in H295R cells and 5 -AD isomerase activity in cell lysates
As hGSTA3-3 is selectively expressed in steroid hormoneproducing organs in humans [8, 10] , we chose the adrenal cell line H295R, known to possess the full enzyme complement required for normal adrenal steroidogenesis, and to produce significant amounts of testosterone [20, 21] . We verified that the cells secreted progesterone and testosterone as expected (results not shown). We found by RT-PCR that hGSTA3-3 is expressed in this cell line, as well as hGSTs A1-1, A2-2 and A4-4 ( Figure 1A) . Two previously described splice variants of hGSTA3-3 were detected [8, 10] . Crude protein extracts were prepared from exponentially growing H295R cells and enzymatic reactions were set up as in the assays with recombinant proteins, except that 15 μl of cell extract was used instead of the recombinant enzymes. 5 -AD isomerase activity was readily detected in crude cell lysates in the presence of 1 mM glutathione. When glutathione was removed only 26 % of the activity remained, whereas 12 % was detected when the lysate was omitted ( Figure 1B) . Thus, in the presence of glutathione, 12 % of the isomerization was non-enzymatic, while glutathionedependent isomerization accounted for 74 % of the total activity measured ( Figure 1C ).
Inhibition of 5 -AD isomerase activity in cell lysates
As shown in Figure 2 , EA and TBTA efficiently inhibited 5 -AD isomerase activity in crude cell lysates. IC 50 values were found to be 5 and 0.4 μM respectively, showing that TBTA is a stronger inhibitor than EA in cell lysates, in accordance with the results obtained with purified enzymes (see Table 1 ).
GSTA expression and progesterone production in JEG-3 cells
The placental cell line JEG-3 was chosen for RNAi (RNA interference) studies. Unstimulated cells were found to express only minute amounts of hGSTA3-3. However, treatment with forskolin, known to increase cellular cAMP levels and to stimulate steroidogenesis [1] , resulted in an increase in the hGSTA3-3 mRNA level ( Figure 3A ). This increase was highly reproducible throughout all treatments with forskolin, and it encompassed also hGSTA3-3 splice variants, as shown in Figure 3(A) . JEG-3 cells produce and release progesterone, which can be measured in the culture medium. Treatment with 10 μM forskolin increased progesterone production as expected ( Figure 3B ). The other human GSTAs were essentially undetectable by RT-PCR in this cell line, even after treatment with forskolin. (Figure 3C ). Only a very weak band corresponding to hGSTA4-4 was detected in control and forskolin-treated cells.
Down-regulation of hGSTA3-3 by RNAi
We designed two alternative siRNAs targeting hGSTA3-3 mRNA. Transfection of either of the hGSTA3-3-specific siRNAs concurrent with forskolin treatment resulted in the lack of production of full-length hGSTA3-3 mRNA. In forskolin-treated cells that received an unrelated control siRNA, the amount of hGSTA3-3 mRNA increased as observed previously (Figure 4) . Thus the designed siRNAs selectively prevented the forskolindependent induction of hGSTA3-3 mRNA. The effect was clearly visible already after 5 h of the combined induction Total RNA was prepared 5, 48 or 48+24 h post-transfection. Here, '48+24 h' refers to a double transfection, where cells were first transfected during 48 h, after which they were trypsinized and transfected a second time for 24 h (for further details, see the Experimental section). An siRNA-targeting hGSTA3-3 mRNA (si1) and a control siRNA (siC) were used. The fragment amplified from full-length hGSTA3 mRNA is indicated (GSTA3 FL). Two shorter splice variants of hGSTA3-3 are detected below GSTA3 FL. The level of 3β-HSD mRNA in siC-and si1-transfected cells is presented in the lower panel. Actin was used as an internal control.
and transfection and lasted for at least 48 h after transfection ( Figure 4 ). As expected, the siRNA targeting the exon 3-exon 4 junction did not affect the expression of splice variants lacking exon 3 [8, 10] . Of note, the silencing procedure did not affect the expression of 3β-HSD mRNA (Figure 4 ).
Attenuation of progesterone production in JEG-3 cells by RNAi
We next investigated whether siRNA-mediated knock-down of hGSTA3-3 in forskolin-treated JEG-3 cells affected their ability to synthesize progesterone. As shown in Figure 5 , the production of progesterone by JEG-3 cells in which hGSTA3-3 is silenced was decreased by 30 %. Concentrations of siRNA down to 4 nM still afforded a reduction of progesterone production ( Figure 5A ). Two dissimilar hGSTA3-3-specific siRNAs both caused the attenuation of progesterone production ( Figure 5B ). In cells not treated with forskolin, and in which hGSTA3-3 expression therefore was very low, silencing of hGSTA3-3 caused a smaller relative decrease in progesterone secretion (10-15 %; Figure 5C ).
DISCUSSION
In the present study, we report the first direct evidence for the involvement of hGSTA3-3 in the biosynthesis of steroid hormones in human cells. We used two different approaches to interfere with hGSTA3-3 function in steroidogenic cells. The first approach was based on the use of EA and TBTA, two inhibitors of the steroid isomerization reaction catalysed by hGSTA3-3. These compounds exhibited a strong inhibitory effect on 5 -4 steroid isomerization in H295R cell lysates. EA and TBTA are also potent inhibitors of hGSTA1-1 (Table 1) , another GST shown to exhibit steroid isomerase activity [8] , although with a lower efficiency than hGSTA3-3. It is therefore possible that the inhibition of steroid isomerase activity observed in cell lysates resulted from the inhibition of not only hGSTA3-3 but also, to some extent, hGSTA1-1. 3β-HSD, which produces the 3-keto-5 steroid substrate, also catalyses the subsequent 5 -4 steroid isomerization, yet with a much lower efficiency than hGSTA3-3 [8] . However, the activity of this enzyme was previously reported to be only marginally affected by TBTA [22] . In addition, NADH, the essential activator of 3β-HSD [23] , was not added to our extracts. Because NADH is required for 3β-HSD steroid isomerase activity, this enzyme is highly unlikely to (A) and (B) , or the vehicle alone (DMSO) or was left untreated (-) was measured. , P < 0.15; *P < 0.05; **P < 0.002; ***P < 0.001. make a significant contribution to the 5 -AD isomerase activity observed in our assay. Altogether, these results show that the GST-dependent steroid isomerization is not restricted to in vitro conditions, but is prominent in a complex biological system such as crude cell lysates, where it can be suppressed by inhibitors of GSTAs.
We next studied the effect of EA and TBTA on the capacity of steroidogenic cells to produce steroid hormones. However, EA and TBTA were found to be highly toxic to cultured H295R cells (results not shown). We therefore chose another human steroidogenic cell line, JEG-3, widely used for studies on steroid hormone-related processes [24] . However, non-toxic concentrations of EA and TBTA failed to diminish progesterone production by cultured JEG-3 cells (results not shown). Possibly, effects of TBTA on other steroidogenic enzymes [25] [26] [27] may mask the consequences of inhibiting hGSTA3-3 on progesterone production. Not much is known about the effect of EA on steroidogenesis, but this electrophilic compound may act unspecifically through its propensity to react with thiol groups. The lack of specificity of these toxic inhibitors renders them unsuitable for in vivo studies of the role of hGSTA3-3 in steroidogenesis. Studies involving specific inhibitors of 3β-HSD (such as trilostane or epostane) would not clarify the relative contribution of hGSTA3-3, since they would block the dehydrogenase activity of 3β-HSD [28] , thereby preventing synthesis of the substrate for the isomerization reaction. To our knowledge, no compound selectively inhibiting the steroid isomerase activity of 3β-HSD has been described.
We therefore chose the highly specific approach of knocking down the hGSTA3 gene expression with RNAi. The resulting attenuation of cellular progesterone production showed that hGSTA3-3 is a significant contributor to progesterone synthesis in JEG-3 cells. In the siRNA-treated cells, expression of the mRNA coding for 3β-HSD, the enzyme to which steroid isomerization is classically attributed [1] , was not affected, and the transfection conditions in the present study minimized the risk of offtarget effects. Moreover, we used cells where the most similar mRNAs (hGSTA1, hGSTA2 and hGSTA4), which might be potential off-targets, are undetectable by RT-PCR or present in minute amounts. The concentration of siRNA transfected was low throughout all experiments, and an attenuation of progesterone production was still observable with a concentration of 4 nM of siRNAs, indicating high specificity. Furthermore, we showed that two siRNAs targeting different regions of hGSTA3 mRNA caused a similar diminution of progesterone production. Finally, a highly significant attenuation of progesterone secretion was observed only in cells where hGSTA3-3 expression was induced by forskolin. The marginal effect in untreated cells, in which 3β-HSD, but not GSTA3-3, is expressed at relatively high levels [29] , also shows that silencing does not affect 3β-HSD function significantly. In the present study, the effect of hGSTA3-3 knockdown on progesterone production in JEG-3 cells was limited to 30 %, which may be due to a compensatory effect of forskolin, which induces 3β-HSD in this cell line [29] . Obviously, the isomerase activity displayed by 3β-HSD could not be expected to be inhibited by eliminating the contribution by hGSTA3-3. However, our results clearly show that the isomerase activity of 3β-HSD is not sufficient for maximal rate of cellular sex hormone production and identify hGSTA3-3 as a significant contributor.
It should be borne in mind that the relative contributions of 3β-HSD and hGSTA3-3 to steroid isomerization may vary among different cell types and under distinct physiological conditions. The present findings therefore warrant further investigation of the possible interplay between 3β-HSD and hGSTA3-3. Previous work indicates that GSTAs are associated with intracellular membranes [30, 31] , suggesting that hGSTA3-3 and 3β-HSD have similar subcellular localizations, which should facilitate functional co-operation between the two enzymes.
In accord with a role for hGSTA3-3 in steroidogenesis, we note that the hGSTA3 gene possesses several features of wellknown steroidogenic enzymes. We describe for the first time the induction of hGSTA3-3 by forskolin, known to increase the level of intracellular cAMP, an essential inducer of steroidogenic enzymes [1] . Moreover, examination of the promoter region of the hGSTA3 gene reveals three putative SF-1 (steroidogenic factor-1)-binding sites, which are not present in the corresponding promoter regions of the closely related hGSTA1 and hGSTA2 genes ( Figure 6 ). The SF-1 transcription factor is involved in the up-regulation of most steroidogenic enzymes [1] . Whether these The promoters of hGSTA1, hGSTA2 and hGSTA3 genes (retrieved from a BLAT search; http://genome.ucsc.edu/) were aligned using the ClustalW software (http://www.ebi. ac.uk/clustalw/). The three putative SF-1-binding sites found in the hGSTA3 promoter are presented in boldface. Nucleotide assignments are indicated in parentheses ('0' denotes the first transcribed nucleotide). *, deletions; '-', identical bases.
sites in the hGSTA3 promoter region are functional in different human steroidogenic tissues remains to be established and is the subject of our ongoing studies.
Several human endocrine disorders, such as the polycystic ovary syndrome [32] , congenital adrenal hyperplasia [33] and Cushing's syndrome [34] , are characterized by excessive steroid hormone production. In addition, sex steroid hormones stimulate neoplastic cell growth in a number of human malignancies, such as prostate and breast cancers [35] . Of note, increased expression of GSTAs has been reported in benign adrenocortical adenoma from patients with Cushing's syndrome [36] . It would be worthwhile to study whether hGSTA3-3 is increased in these tissues and in other pathological conditions involving increased steroid hormone production. Further studies are warranted in order to fully comprehend the importance of hGSTA3-3 in human steroidogenesis. However, the present study provides not only evidence for a role of hGSTA3-3 in this important biological process, but also proffers the enzyme as a new possible target to reduce steroid hormone production in human cells.
